CA2596799A1 - Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer - Google Patents

Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer Download PDF

Info

Publication number
CA2596799A1
CA2596799A1 CA002596799A CA2596799A CA2596799A1 CA 2596799 A1 CA2596799 A1 CA 2596799A1 CA 002596799 A CA002596799 A CA 002596799A CA 2596799 A CA2596799 A CA 2596799A CA 2596799 A1 CA2596799 A1 CA 2596799A1
Authority
CA
Canada
Prior art keywords
cells
aralkyl
heteroaryl
aryl
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002596799A
Other languages
English (en)
Inventor
Vladimir Khazak
Erica A. Golemis
Sanjay R. Menon
Lutz Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fox Chase Cancer Center
NexusPharma Inc
Original Assignee
Nexuspharma Inc.
Fox Chase Cancer Center
Vladimir Khazak
Erica A. Golemis
Sanjay R. Menon
Lutz Weber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexuspharma Inc., Fox Chase Cancer Center, Vladimir Khazak, Erica A. Golemis, Sanjay R. Menon, Lutz Weber filed Critical Nexuspharma Inc.
Publication of CA2596799A1 publication Critical patent/CA2596799A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002596799A 2005-02-02 2006-02-02 Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer Abandoned CA2596799A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64947005P 2005-02-02 2005-02-02
US60/649,470 2005-02-02
PCT/US2006/003817 WO2006084116A2 (fr) 2005-02-02 2006-02-02 Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer

Publications (1)

Publication Number Publication Date
CA2596799A1 true CA2596799A1 (fr) 2006-08-10

Family

ID=36777960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002596799A Abandoned CA2596799A1 (fr) 2005-02-02 2006-02-02 Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer

Country Status (5)

Country Link
EP (1) EP1845985A4 (fr)
JP (1) JP2008528697A (fr)
AU (1) AU2006210537A1 (fr)
CA (1) CA2596799A1 (fr)
WO (1) WO2006084116A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926297B1 (fr) 2008-01-10 2013-03-08 Centre Nat Rech Scient Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage.
EP3120863B1 (fr) * 2008-02-29 2020-05-06 Acorda Therapeutics, Inc. Compositions permettant de fournir les niveaux de plasma désirés du facteur 2 de croissance gliale
EP2505198A1 (fr) 2011-04-01 2012-10-03 Société Splicos Composés pour leur utilisation en tant qu'agents thérapeutiques affectant l'expression et/ou l'activité de p53

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
US6369226B1 (en) * 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
WO2002100846A1 (fr) * 2001-06-11 2002-12-19 Shire Biochem Inc. Composes et methodes de traitement ou de prevention d'infections a flavivirus
US20050228017A1 (en) * 2001-10-31 2005-10-13 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Novel anticancer compounds
US20040166137A1 (en) * 2002-11-08 2004-08-26 Lackey John William Hetero-substituted benzimidazole compounds and antiviral uses thereof

Also Published As

Publication number Publication date
EP1845985A4 (fr) 2011-10-12
EP1845985A2 (fr) 2007-10-24
AU2006210537A1 (en) 2006-08-10
WO2006084116A2 (fr) 2006-08-10
JP2008528697A (ja) 2008-07-31
WO2006084116A3 (fr) 2007-06-07

Similar Documents

Publication Publication Date Title
CN109153640B (zh) 用抗病毒剂消除乙型肝炎病毒
Tan et al. Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1, 3, 4]-oxadiazoles as potential anti-hepatitis B virus agents
CN103561576B (zh) 脂质合成的杂环调节剂
CN110023304A (zh) 钙蛋白酶调节剂及其治疗用途
CN108348529A (zh) 乙型肝炎核心蛋白调节剂
US9168269B2 (en) Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals
KR20090018593A (ko) 세포괴사 저해제로서의 인돌 및 인다졸 화합물
CA2810706C (fr) Amide substitue
US20150139949A1 (en) Anti-viral combination therapy
US7705021B2 (en) Isoindolone compounds, compositions containing the same, and methods of use thereof for the treatment of viral infections related to the etiology of cancer
WO2011106627A1 (fr) Acides hydroxamiques substitués et leurs utilisations
BRPI0413430B1 (pt) Derivados de amida os um sal destes, composição farmacêutica compreendendo os mesmos e uso destes para o tratamento de doenças em que está implicado o Herpesvírus.
CN110177551A (zh) 脂质合成的杂环调节剂
CA2596799A1 (fr) Compositions contenant des derives amine et procedes permettant de traiter des infections virales associees a l'etiologie du cancer
JP6041877B2 (ja) キナゾリノン類似体及び特定のウイルス感染症の治療又は予防へのキナゾリノン類似体の使用
WO2006082821A1 (fr) Agent preventif ou therapeutique contre une maladie liee au virus de l'herpes
CA2881901C (fr) Carboxamides heterocyclyle pour le traitement de maladies virales
CN117255686A (zh) Vps34抑制剂的抗病毒活性
JP2023550638A (ja) ウイルス感染症の処置に使用するための、vsp34阻害剤としてのモルホリノ誘導体
CN117241800A (zh) Vps34抑制剂的抗病毒活性
JP2023550641A (ja) ウイルス感染症の治療に使用するためのvsp34阻害剤としてのモルホリノ誘導体
JP2023550640A (ja) Vps34阻害剤の抗ウイルス活性
JP2023553809A (ja) ウイルス感染の治療に使用するためのvsp34阻害剤としてのピリジルピリドン誘導体
JP2003063993A (ja) 医薬組成物
CN111407767B (zh) 一种磺胺间甲氧嘧啶衍生物在制备抗肿瘤药物中的应用

Legal Events

Date Code Title Description
FZDE Dead